EN
HI
Summary
As of 25 Aug, 2026, Senores Pharmaceuticals stock price is ₹1480.4. During the trading session, the stock has moved between an intraday low of ₹1456.30 and an intraday high of ₹1508.00. Over the last 52 weeks, Senores Pharmaceuticals has traded between ₹662.45 and ₹1599.00.
The stock has recorded a trading volume of 1,98,519 shares, with a market capitalization of ₹46053588. Its Average Traded Price (ATP) is ₹1485.26, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹1480.40.
Senores Pharmaceuticals has an upper circuit limit of ₹1818.80 and a lower circuit limit of ₹1212.60. The total value traded stands at ₹29.49 CR, and the delivery percentage for the day is 39.76%.
The stock is currently traded with a market lot size of 1. Senores Pharmaceuticals also offers a dividend yield of 0%.
Senores Pharmaceuticals share price chart
Senores Pharmaceuticals Share Key Metrics
Volume
1.99 L
Market Cap
6817.77 CR
LTQ@LTP
2@1480.40
ATP
1485.26
Var Margin
20.51 %
Circuit Range
1212.6-1818.8
Delivery %
39.76 %
Value
29.49 CR
ASM/GSM
No
Market Lot
1
Senores Pharmaceuticals Fundamentals
P/E Ratio
55.31
P/B Ratio
7.25
Div. Yield
0
Sector P/E
69.22
Sector P/B
3.36
Sec. Div. Yield
0.51
Senores Pharmaceuticals Resistance and Support
Pivot 1535.6
Resistance
First Resistance
1579.1
Second Resistance
1642.5
Third Resistance
1686
Support
First Support
1472.2
Second Support
1428.7
Third Support
1365.3
Senores Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 25 2026 | 1508 | 1480.4 | -2.33% | 1508 | 1456.3 |
| Mon Aug 24 2026 | 1521 | 1515.69 | 0.16% | 1599 | 1492.09 |
| Fri Aug 21 2026 | 1519.8 | 1513.3 | 0.00% | 1537.19 | 1495.69 |
Senores Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-27 | Quarterly Results |
| 2026-05-14 | Audited Results |
| 2026-01-20 | Quarterly Results & Others |
| 2026-01-07 | Others |
| 2025-11-06 | Quarterly Results |
| 2025-07-23 | Quarterly Results & Others |
| 2025-05-15 | Audited Results |
| 2025-01-23 | Quarterly Results & Others |
Senores Pharmaceuticals News
Senores Pharmaceuticals Ltd - 544319 - Intimation For Giving Corporate Guarantee For Credit Facilities Availed By Apnar Pharma Private Limited, Subsidiary Of The Company From ICICI Bank Limited
Senores Pharmaceuticals issued a corporate guarantee of Rs.62 crore for credit facilities availed by its subsidiary, Apnar Pharma Private Limited, from ICICI Bank Limited. This is noted as a contingent liability in the financial statements.
Aug 24 2026 17:42:36
Senores Pharmaceuticals Ltd - 544319 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Senores Pharmaceuticals' shareholders approved all 8 postal ballot resolutions. Key approvals include enhancing inter-corporate loan/guarantee limits under Sections 185 and 186, and adjusting the utilization terms and timeline for IPO proceeds. These approvals provide increased financial and operational flexibility.
Aug 04 2026 17:51:33
Read More
Senores Pharmaceuticals Management
| Name | Position |
|---|---|
| Vinay Kumar Mishra | Company Secretary & Compliance Officer |
| Swapnil Jatinbhai Shah | Managing Director |
Senores Pharmaceuticals Similar Stocks
Thyrocare Technologies Ltd.
596.05
12.05 (2.06%)
Procter & Gamble Health Ltd.
5833.00
-40.50 (0.69%)
Yatharth Hospital & Trauma Care Services Ltd.
923.05
15.50 (1.71%)
Sanofi India Ltd.
3198.20
-76.40 (2.33%)
Aarti Pharmalabs Ltd.
834.95
-8.20 (0.97%)
Nephrocare Health Services Ltd.
697.35
10.10 (1.47%)
Kovai Medical Center & Hospital Ltd.
5985.50
60.00 (1.01%)
Innova Captab Ltd.
1040.40
-22.65 (2.13%)
Bliss GVS Pharma Ltd.
561.50
-3.40 (0.60%)
Orchid Pharma Ltd.
1038.55
0.45 (0.04%)
Senores Pharmaceuticals FAQs
The Buying Price of Senores Pharmaceuticals share is 1480.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Senores Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Senores Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Senores Pharmaceuticals shares is 55.31. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Senores Pharmaceuticals shares is 7.25. Useful to assess the stock's value relative to its book value.
To assess Senores Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.22 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Senores Pharmaceuticals is 6817.77 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Senores Pharmaceuticals share price is 1599.00 & 662.45. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Senores Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
